Axon Enterprise (AXON) 8-K TASER Reports Record Quarterly Revenue of $56.0 million

TASER International, Inc. OPERATING METRICS (UNAUDITED) Q4 Q3 Q2 Q1 Q4 Axon & Evidence.com Bookings (millions) 44.7$ 36.9$ 30.6$ 22.9$ 24.6$ Sequential % Change 21% 21% 34% -7% Active Paid Seats (1) 45,900 33,000 29,000 22,000 18,000 Sequential % Change 39% 14% 32% 22% Annual Recurring Revenue (millions) (2) 16.7$ 12.0$ 9.8$ 7.8$ Average Monthly Revenue Per User** 44.7$ 27.6$ 29.0$ 26.8$ 26.5$ Future Billings (millions) (3)* 132.8$ 99.2$ 77.7$ 56.3$ 39.3$ Sequential % Change 34% 28% 38% 43% Future Contracted Revenue (millions) (4) 159.0$ 122.4$ 94.9$ 71.1$ 53.6$ Sequential % Change 30% 29% 33% 33% Attachment Rate (5)* 84% 79% 77% 80% 80% Multiple Year Contract % (6) 92% 91% 88% 90% 90% LTV/CAC 4.3 4.6 4.5 3.5 3.9 Weapons Op Inc % 37.4% 35.4% 38.6% 40.6% 36.6% Evidence.com new seats booked 13,200 9,300 Evidence.com cumulative seats booked 59,000 45,800 (1) The seats that are included in the revenue recognition as of the period end (2) Monthly recurring license, integration, warranty and storage revenue annualized. (5) Out of all the cameras sold in the quarter, the number that also bought Evidence.com (6) For orders booked with Evidence.com seats, the % that signed multiple year contracts * Indicates disclosure that will be discontinued in 2016 **ARPU calculation does not accurately reflect the recurring nature of service revenue due to the variability of catch-up revenue quarter to quarter. The Q4 ARPU of $44.7 includes $0.9 million of catch-up revenue. Please listen to our Q4 2015 earnings conference call for further ARPU discussion and alternative metrics that more accurately capture our recurring user revenue. 2014 (4) Cumulative bookings for Axon and Evidence.com minus cumulative recognized revenue related solely to Axon and Evidence.com 2015 (3) Cumulative bookings for Axon and Evidence.com to date net of cumulated Axon camera and Evidence.com recognized revenue and Axon camera and Evidence.com deferred revenue balances